The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) is focused on the development and commercialization of KETARX™ (Ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, ...
In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...
The Trump administration is being urged to shut down two controversial, NYC-government approved “safe injection sites” — ...
Hims & Hers hit the bullseye with its Super Bowl ad—it sparked a lot of attention from consumers. | Hims & Hers hit the ...
The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...
The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...
It’s been three months since California voters overwhelmingly approved Proposition 36, a new law that pledged to provide ...
In response to complaints made publicly by the Partnership for Safe Medicine and the Obesity Society, Hims & Hers provided ...
Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment ...
A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...
Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to bar the game’s host, Fox, from broadcasting it. Why? Experts, advocates and ...